Breaking News Instant updates and real-time market news.

HCM

Hutchison China MediTech

$17.90

-0.59 (-3.19%)

16:58
09/29/19
09/29
16:58
09/29/19
16:58

Hutchison China MediTech presents results from Phase III stufe of surufatinib

Hutchison China MediTech presented the results of the Phase III study of surufatinib in advanced neuroendocrine tumors - extra-pancreatic at the 2019 European Society for Medical Oncology Congress. The study has met the pre-defined primary endpoint of progression free survival early. Patients treated with surufatinib were 67% less likely to see their disease progress or die as compared to patients on placebo control, assessed by local investigators. As announced in June 2019, the independent Data Monitoring Committee for the trial recommended that the study stop early because it had met the pre-defined primary endpoint of PFS during a planned interim analysis. Preparations are now underway for the potential NDA submission by year end 2019 for this indication in China. At data cut-off as of March 31, 2019, 198 patients were randomized 2:1 to treatment with either 300 mg of surufatinib orally daily or placebo control on a 28-day cycle. Median PFS per investigator assessment was 9.2 months for patients treated with surufatinib, as compared to 3.8 months for patients in the placebo group. The efficacy of surufatinib was seen across all subgroups, and supported by statistically significant improvement as measured by secondary efficacy endpoints including objective response rate, disease control rate, time to response, duration of response, safety, and tolerability. Efficacy was also supported by Blinded Independent Image Review Committee assessment. Overall survival data was not mature, with only 18.7% OS events at data cut-off. Surufatinib was generally well-tolerated in this study and the safety profile is consistent with observations in prior clinical studies.

HCM Hutchison China MediTech
$17.90

-0.59 (-3.19%)

03/04/19
DBAB
03/04/19
INITIATION
Target $35
DBAB
Buy
Hutchison China MediTech initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Richard Parkes started Hutchison China MediTech with a Buy rating and $35 price target. The analyst believes the shares offer "significant upside potential" as the company leverages its pipeline of cancer-focused drugs in both domestic and global markets.
03/27/19
HSBC
03/27/19
INITIATION
HSBC
Buy
Hutchison China MediTech initiated with a Buy at HSBC
HSBC analyst Steve McGarry earlier today initiated coverage of Hutchison China MediTech with a Buy rating and 5,940 pence price target. The company's late stage oncology pipeline assets are "promising" and "could be transformative," McGarry told investors in a research note. Further, Hutchison has "significant" Pharma and Consumer Health businesses in China that generate sales and profits, adds the analyst.
07/05/19
MACQ
07/05/19
INITIATION
MACQ
Outperform
Hutchison China MediTech initiated with an Outperform at Macquarie

TODAY'S FREE FLY STORIES

TER

Teradyne

$58.91

-1.35 (-2.24%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Teradyne to acquire AutoGuide Mobile Robots for $165M »

Teradyne and AutoGuide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

RESN

Resonant

$2.32

-0.12 (-4.92%)

07:01
10/21/19
10/21
07:01
10/21/19
07:01
Hot Stocks
Resonant says customers shipped more than 1.5M units in Q3 »

Resonant announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

GCI

Gannett

$10.91

-0.01 (-0.09%)

, NEWM

New Media

$8.89

0.08 (0.91%)

06:59
10/21/19
10/21
06:59
10/21/19
06:59
Periodicals
Gannett, New Media deal could be in jeopardy due to regulatory glitch, NYP says »

The proposed acquisition…

GCI

Gannett

$10.91

-0.01 (-0.09%)

NEWM

New Media

$8.89

0.08 (0.91%)

APO

Apollo Global

$39.96

-0.06 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

LNG

Cheniere Energy

$62.51

0.05 (0.08%)

06:58
10/21/19
10/21
06:58
10/21/19
06:58
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

AUB

Atlantic Union Bankshares

$37.68

0.37 (0.99%)

06:57
10/21/19
10/21
06:57
10/21/19
06:57
Downgrade
Atlantic Union Bankshares rating change  »

Atlantic Union Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 13

    Nov

  • 10

    Dec

CBU

Community Bank System

$63.64

0.58 (0.92%)

06:54
10/21/19
10/21
06:54
10/21/19
06:54
Earnings
Community Bank System reports Q3 operating EPS 84c, consensus 81c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

MDT

Medtronic

$108.18

-0.365 (-0.34%)

06:53
10/21/19
10/21
06:53
10/21/19
06:53
Hot Stocks
Medtronic names Sean Salmon as EVP, Group President of Medtronic Diabetes »

Medtronic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BMRN

BioMarin

$69.16

1.27 (1.87%)

06:53
10/21/19
10/21
06:53
10/21/19
06:53
Recommendations
BioMarin analyst commentary  »

Cantor sees successful…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 23

    Oct

  • 07

    Dec

KMT

Kennametal

$30.73

0.9 (3.02%)

06:53
10/21/19
10/21
06:53
10/21/19
06:53
Earnings
Kennametal cuts FY20 adj. EPS view to $1.70-$2.10 from $2.80-$3.20 

Consensus $2.81.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 14

    Nov

KMT

Kennametal

$30.73

0.9 (3.02%)

06:52
10/21/19
10/21
06:52
10/21/19
06:52
Hot Stocks
Kennametal CEO says Q1 results are well below expectations »

"Our first quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 14

    Nov

CFWFF

Calfrac Well Services

$0.00

(0.00%)

06:50
10/21/19
10/21
06:50
10/21/19
06:50
Downgrade
Calfrac Well Services rating change  »

Calfrac Well Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$18.44

-0.07 (-0.38%)

06:50
10/21/19
10/21
06:50
10/21/19
06:50
Hot Stocks
Halliburton CEO says 'our organization executed effectively' in Q3 »

"Our organization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 13

    Nov

PTON

Peloton

$23.44

-0.41 (-1.72%)

, BABA

Alibaba

$169.18

-7.665 (-4.33%)

06:49
10/21/19
10/21
06:49
10/21/19
06:49
Recommendations
Peloton, Alibaba analyst commentary  »

Stifel adds Peloton to…

PTON

Peloton

$23.44

-0.41 (-1.72%)

BABA

Alibaba

$169.18

-7.665 (-4.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 19

    Nov

KMT

Kennametal

$30.73

0.9 (3.02%)

06:48
10/21/19
10/21
06:48
10/21/19
06:48
Earnings
Kennametal reports preliminary Q1 adj. EPS 17c, consensus 49c »

Reports preliminary Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 14

    Nov

CBU

Community Bank System

$63.64

0.58 (0.92%)

06:48
10/21/19
10/21
06:48
10/21/19
06:48
Hot Stocks
Community Bank System acquires Steuben Trust for $106.8M »

Community Bank System and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

SGEN

Seattle Genetics

$87.42

1.48 (1.72%)

06:48
10/21/19
10/21
06:48
10/21/19
06:48
Hot Stocks
Seattle Genetics says HER2CLIMB trial met primary endpoint »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 07

    Dec

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:47
10/21/19
10/21
06:47
10/21/19
06:47
Initiation
Peloton initiated  »

Peloton initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PINS

Pinterest

$25.30

-0.7 (-2.69%)

06:46
10/21/19
10/21
06:46
10/21/19
06:46
Upgrade
Pinterest rating change  »

Pinterest upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 19

    Nov

HAL

Halliburton

$18.44

-0.07 (-0.38%)

06:45
10/21/19
10/21
06:45
10/21/19
06:45
Earnings
Halliburton reports Q3 EPS 34c, consensus 34c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 13

    Nov

CMG

Chipotle

$841.97

13.88 (1.68%)

06:42
10/21/19
10/21
06:42
10/21/19
06:42
Recommendations
Chipotle analyst commentary  »

Chipotle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Nov

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:42
10/21/19
10/21
06:42
10/21/19
06:42
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$344.09

-25.04 (-6.78%)

06:39
10/21/19
10/21
06:39
10/21/19
06:39
Downgrade
Credit Suisse can no longer defend Boeing shares, downgrades to Neutral »

Credit Suisse analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GIL

Gildan Activewear

$26.27

-9.105 (-25.74%)

06:36
10/21/19
10/21
06:36
10/21/19
06:36
Downgrade
Gildan Activewear rating change  »

Gildan Activewear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

OPRT

Oportun Financial

$15.89

-0.22 (-1.37%)

06:36
10/21/19
10/21
06:36
10/21/19
06:36
Initiation
Oportun Financial initiated  »

Oportun Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONB

Old National Bancorp

$17.19

0.11 (0.64%)

06:35
10/21/19
10/21
06:35
10/21/19
06:35
Earnings
Old National Bancorp reports Q3 adjusted EPS 41c, consensus 34c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.